Tranzyme, Inc. (TZYM) Reports Q4 Loss of $0.33, Sales Fall Short

Tranzyme, Inc. (NASDAQ: TZYM) reported Q4 EPS of ($0.33), $0.02 worse than the analyst estimate of ($0.31). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $2.43 million.

For earnings history and earnings-related data on Tranzyme, Inc. (TZYM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Bernstein SocGen Group Reiterates Outperform Rating on JD.com, Inc (JD), 'very cheaply valued'
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c